Navigation Links
Mayo Clinic study guides physicians using therapeutic cooling to treat cardiac arrest patients
Date:10/19/2011

ROCHESTER, Minn. - Sudden cardiac arrest is the leading cause of death in the United States, and just 7 percent of victims survive that initial collapse. In addition, fewer than half of the small percentage of people whose hearts are restarted survive to leave the hospital, because they often suffer irreversible brain damage. A Mayo Clinic study published this month in the journal Neurology provides guidance to physicians using therapeutic cooling to treat sudden cardiac arrest patients.

One relatively new approach to prevent or reduce brain damage involves the use of hypothermia - forced cooling - of the patient as soon as possible following sudden cardiac arrest. The aim is to slow the body's metabolism and reduce the cascade of undesirable events that can cause permanent brain damage. It is believed that mild therapeutic hypothermia suppresses harmful chemical reactions in the brain and preserves cell health.

One concern about the use of hypothermia for cardiac arrest patients is that it might delay a patient's post-event awakening. This is important because an evaluation 72 hours after the patient's collapse is useful in determining the prognosis, especially if the patient is awake.

Mayo Clinic researchers, however, found that both patient groups - those who were and were not treated with therapeutic hypothermia - awoke an average of two days post-collapse, with nearly all patients in both groups awakening within three days.

"After sudden cardiac arrest, the use of therapeutic hypothermia can make a difference, not only in terms of survival but also allowing more patients to recover without significant brain damage," says senior author Alejandro Rabinstein, M.D., a Mayo Clinic neurologist. "Our study relieves concerns about delayed awakening associated with hypothermia and supports its use when indicated."

In addition to these findings, the researchers also report that:

  • The median day of awakening was day two for both hypothermic and non-hypothermic patients.
  • Ninety-one percent of hypothermic patients and 79 percent of non-hypothermic patients awoke within three days following their collapse.
  • Overall in-hospital mortality was 53 percent.

Also reported was that:

  • Sixty-four percent of patients treated with induced hypothermia survived.
  • Just 24 percent of patients not treated with hypothermia survived.


'/>"/>

Contact: Brian Kilen
newsbureau@mayo.edu
507-284-5005
Mayo Clinic
Source:Eurekalert

Related medicine news :

1. The West Clinic Joins Cancer Clinics of Excellence (CCE)
2. Stethoscope App gives iPhone New Clinical Skills
3. Mayo Clinic responsible for $22 billion in economic impact, including $9.6 billion in Minnesota
4. Sunquest Introduces Integrated Clinical Environment Physician Portal Solution in US
5. Almac Launches New STEMS System to Transform Temperature Controlled Shipment Monitoring in Clinical Trials
6. Clinical trial underway: Miniature ultrasound device could revolutionize pain relief
7. Sunquest Completes System-Wide Implementation at Cleveland Clinic Hospital Laboratories
8. Michael J. Fox Foundation Awards $1.1 Million For Clinical Trial of Transdermal Nicotine as Disease-Modifying Treatment For Parkinsons
9. NOVAVAX Presents Positive Clinical Results at The World Health Organization Conference, Geneva, Switzerland
10. UCLA Health System Presents: How to Successfully Implement a Clinical Portal
11. International Merchant Advisors CEO Mel Roseman to Discuss New Medical Marijuana Clinics Live on CBS Radio Networks Big Biz Show February 22, 2010 at 1:40 pm PST
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... ... 09, 2016 , ... Traumatic Brian Injury is often in ... one of many possible sources: sports, car accidents, falls, work accidents, combat and ... Rehab Solutions for the Complexities of Concussions is designed for physical and ...
(Date:2/9/2016)... ... 09, 2016 , ... Center for Autism and Related Disorders ... spectrum disorder (ASD). Beginning Jan. 1, 2016, Medicaid is covering autism treatment in ... key to providing effective treatment for individuals with ASD. Now, over 1,800 low-income ...
(Date:2/9/2016)... ... February 09, 2016 , ... URise Products announces today ... device, the StandUp Walker. Made entirely in the USA, the StandUp Walker is ... , StandUp Walker’s novel patent-pending design offers 2-in-1 benefits of a stand-assist ...
(Date:2/9/2016)... (PRWEB) , ... February 09, ... ... print and e-book publishing software, in partnership with Snowfall4pod Digital, creators of ... a comprehensive book publishing, content management, global distribution and print-on-demand network. , ...
(Date:2/9/2016)... ... February 09, 2016 , ... On January 12, 2016 Paul McElwee, a ... they noticed their furnace not producing any heat. Shortly after entering the home, Paul ... exchanger was leaking dangerous levels of carbon monoxide into the home, at 2,000 parts ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... 10, 2016 --> ... Therapeutics and Companion Diagnostic Market to 2019 - ... Environment" research report indicates that the core personalized ... by 2020 growing at a CAGR of 8.74%. ... and targeted therapeutics and is dominated by oncology, ...
(Date:2/10/2016)... February 10, 2016 Demonstrates ... 1 receptor selectivity   1 ... which has entered clinical development as a new ... and schizophrenia.   --> 1 ... has entered clinical development as a new treatment ...
(Date:2/9/2016)... Inc. (NASDAQ: MSON ), an international surgical ... therapeutic ultrasonic products for spine surgery, skull-based surgery, ... other surgical applications, today announced financial results for ... fiscal year 2016 ended December 31, 2015. ... Highlights for the second quarter and first half ...
Breaking Medicine Technology: